Xin Fan

Notable Publications:

Baum RP, Fan X, Jakobsson V, Schuchardt C, Chen X, Yu F, Zhang J. Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles. Eur J Nucl Med Mol Imaging. 2024;51(4):1136-1146.

Baum RP, Fan X, Jakobsson V, Yu F, Schuchardt C, Chen X, Zhang J. Long-term nephrotoxicity after PRRT: myth or reality. Theranostics. 2024;14(2):451-459.

Fan X, Zhang H, Wang Z, Zhang X, Qin S, Zhang J, Hu F, Yang M, Zhang J, Yu F. Diagnosing postoperative lymph node metastasis in thyroid cancer with multimodal radiomics and clinical features. Digit Health. 2024;10:20552076241233244.

Fan X, Zhang H, Yin Y, Zhang J, Yang M, Qin S, Zhang X, Yu F. Texture analysis of (18)F-FDG PET/CT for differential diagnosis of spinal metastases. Front Med (Lausanne). 2020;7:605746.

Huang Y, Zhang H, Fan X, Wang J, Yin Y, Zhang Y, Shi K, Yu F. The role of gut microbiota and trimethylamine N-oxide in cardiovascular diseases. J Cardiovasc Transl Res. 2023;16(3):581-589.

Qin S, Yang Y, Zhang J, Yin Y, Liu W, Zhang H, Fan X, Yang M, Yu F. Effective treatment of SSTR2-positive small cell lung cancer using (211)At-containing targeted α-particle therapy agent which promotes endogenous antitumor immune response. Mol Pharm. 2023;20(11):5543-5553.

Wang J, Fan X, Qin S, Shi K, Zhang H, Yu F. Exploration of the efficacy of radiomics applied to left ventricular tomograms obtained from D-SPECT MPI for the auxiliary diagnosis of myocardial ischemia in CAD. Int J Cardiovasc Imaging. 2022;38(2):465-472.

Wang Z, Fan X, Zha X, Xu Y, Yin Z, Rixiati Y, Yu F. A proposed modified staging system for medullary thyroid cancer: a SEER analysis with multicenter validation. Oncologist. 2024;29(1):e59-e67.

Xie W, Zhang H, Qin S, Zhang J, Fan X, Yin Y, Liang R, Long H, Yi W, Fu D, et al. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis. Gene. 2019;720:144088.

Xie W, Zhang J, Zhong P, Qin S, Zhang H, Fan X, Yin Y, Liang R, Han Y, Liao Y, et al. Expression and potential prognostic value of histone family gene signature in breast cancer. Exp Ther Med. 2019;18(6):4893-4903.

Yang M, Liu H, Lou J, Zhang J, Zuo C, Zhu M, Zhang X, Yin Y, Zhang Y, Qin S, et al. Alpha-emitter radium-223 induces STING-dependent pyroptosis to trigger robust antitumor immunity. Small. 2023:e2307448.

Yang M, Yin Y, Zhang J, Yi W, Liu J, Chen D, Zhang H, Fan X, Zhang Y, Zhu M, et al. Cytokines: application in recurrence appraisal for differentiated thyroid carcinoma and their relation with radioiodine ablation. J Cell Biochem. 2021;122(10):1350-1359.

Yin YZ, Yao SH, Li CG, Ma YS, Kang ZJ, Zhang JJ, Jia CY, Hou LK, Qin SS, Fan X, et al. Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma. Am J Transl Res. 2021;13(1):168-182.

Zhang H, Caobelli F, Che W, Huang Y, Zhang Y, Fan X, Hu X, Xu C, Fei M, Zhang J, et al. The prognostic value of CZT SPECT myocardial blood flow (MBF) quantification in patients with ischemia and no obstructive coronary artery disease (INOCA): a pilot study. Eur J Nucl Med Mol Imaging. 2023;50(7):1940-1953.

Zhang H, Che W, Shi K, Huang Y, Xu C, Fei M, Fan X, Zhang J, Hu X, Hu F, et al. FT4/FT3 ratio: a novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients. Front Endocrinol (Lausanne). 2022;13:1021326.

Zhang H, Fan X, Qin S, Zhang J, Yin Y, Yang M, Yu F. Left ventricular mechanical dyssynchrony assessment in obese patients using the cadmium-zinc telluride SPECT camera. Int J Cardiovasc Imaging. 2020;36(4):757-765.

Zhang H, Shi K, Fei M, Fan X, Liu L, Xu C, Qin S, Zhang J, Wang J, Zhang Y, et al. A left ventricular mechanical dyssynchrony-based nomogram for predicting major adverse cardiac events risk in patients with ischemia and no obstructive coronary artery disease. Front Cardiovasc Med. 2022;9:827231.

Zhang J, Li F, Yin Y, Liu N, Zhu M, Zhang H, Liu W, Yang M, Qin S, Fan X, et al. Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progression. Biomater Res. 2022;26(1):44.

Zhang J, Yang M, Fan X, Zhu M, Yin Y, Li H, Chen J, Qin S, Zhang H, Zhang K, et al. Biomimetic radiosensitizers unlock radiogenetics for local interstitial radiotherapy to activate systematic immune responses and resist tumor metastasis. J Nanobiotechnology. 2022;20(1):103.

Zhang S, Zhang J, Fan X, Liu H, Zhu M, Yang M, Zhang X, Zhang H, Yu F. Ionizing radiation-induced ferroptosis based on nanomaterials. Int J Nanomedicine. 2022;17:3497-3507.

Zhang X, Zhang H, Zhang J, Yang M, Zhu M, Yin Y, Fan X, Yu F. The paradoxical role of radiation-induced cGAS-STING signalling network in tumour immunity. Immunology. 2023;168(3):375-388.

Zhu M, Yang M, Zhang J, Yin Y, Fan X, Zhang Y, Qin S, Zhang H, Yu F. Immunogenic cell death induction by ionizing radiation. Front Immunol. 2021;12:705361.